Open Access
| Issue |
Med Sci (Paris)
Volume 42, Number 4, Avril 2026
|
|
|---|---|---|
| Page(s) | 325 - 327 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2026044 | |
| Published online | 24 April 2026 | |
- Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 2018 ; 24 : 541-50. [Google Scholar]
- Sharma P, Goswami S, Raychaudhuri D, et al. Immune checkpoint therapy: current perspectives and future directions. Cell 2023 ; 186 : 1652-69. [Google Scholar]
- Park MD, Belabed M, Chen ST, et al. On the biology and therapeutic modulation of macrophages and dendritic cells in cancer. Annu Rev Cancer Biol 2023 ; 7 : 291-311. [Google Scholar]
- Mulder K, Patel AA, Kong WT, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 2021 ; 54 : 1883-900. [Google Scholar]
- Rannikko JH, Hollmén M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer 2024 ; 131 : 627-40. [Google Scholar]
- Hegde S, Giotti B, Soong BY, et al. Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours. Nature 2025 ; 646 : 1214-22. [Google Scholar]
- Park MD, Reyes-Torres I, LeBerichel J, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol 2023 ; 24 : 792-801. [Google Scholar]
- Casanova-Acebes M, Dalla E, Leader AM, et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 2021 ; 595 : 578-84. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.